Log in to save to my catalogue

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e37d05b1c20b4f23851267351eb19f82

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

About this item

Full title

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2022-01, Vol.7 (1), p.12-12, Article 12

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Vaccination with typhoid conjugate vaccines (TCV) is a major part of typhoid prevention. However, little is known about long-term immune persistence following vaccination with TCVs. In this phase-2, randomized double-blind trial (NCT03527355), 285 children aged 6–23 months were randomized to one of three groups: (1) the group that received a first...

Alternative Titles

Full title

Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e37d05b1c20b4f23851267351eb19f82

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e37d05b1c20b4f23851267351eb19f82

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-022-00434-8

How to access this item